Allergan Adds To Growth Areas With Acquisition Of Eye-Disease Compounds
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal with UK’s Asterand nets preclinical prostaglandin receptor agonists with potential in glaucoma, other eye conditions.
You may also be interested in...
Alcon To Try Glaxo’s Ariflo For Dry Eye
Swiss firm builds pipeline with help from GSK and Origenis in latest eye care in-licensing deals.
Alcon To Try Glaxo’s Ariflo For Dry Eye
Swiss firm builds pipeline with help from GSK and Origenis in latest eye care in-licensing deals.
Acucela, Otsuka Enter Deals For Eye Drugs
Early stage and late stage pacts add proof of Japan’s growing interest in the U.S.